Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
10.06
+0.04 (+0.35%)
Delayed Quote
Updated: 11:08 AM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ADMA Biologics Inc - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Bragar Eagel & Squire, P.C. Is Investigating ADMA Biologics, Napco, and L&W and Encourages Investors to Contact the Firm
October 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
October 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
↗
October 15, 2024
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January.
Via
Investor's Business Daily
Key Takeaways From ADMA Biologics Analyst Ratings
↗
October 14, 2024
Via
Benzinga
This Is What Whales Are Betting On ADMA Biologics
↗
October 10, 2024
Via
Benzinga
IBD 50's Top Stock, ADMA Biologics, Crashes After Auditor Unexpectedly Resigns
↗
October 10, 2024
The company reiterated its outlook for 2024 and 2025.
Via
Investor's Business Daily
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
↗
October 14, 2024
Alkermes develops treatments for neurodegenerative diseases (conditions that damage and destroy parts of the nervous system) and cancer.
Via
Investor's Business Daily
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 10, 2024
Via
Benzinga
Exploring high growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).
↗
October 08, 2024
Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock.
Via
Chartmill
Looking for growth without the hefty price tag? Consider NASDAQ:ADMA.
↗
September 24, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:ADMA.
Via
Chartmill
In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
↗
September 20, 2024
Via
Benzinga
Assessing ADMA Biologics: Insights From 4 Financial Analysts
↗
August 12, 2024
Via
Benzinga
ADMA Biologics Set to Join S&P SmallCap 600 Index
September 17, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
What's Going On With ADMA Biologics Stock Monday?
↗
September 09, 2024
ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.
Via
Benzinga
Topics
Stocks
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
↗
September 09, 2024
Via
Benzinga
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
↗
September 05, 2024
Building your watch list, look for stocks with an 80-plus RS Rating. Keros Therapeutics stock just met that criteria with a new score of 86.
Via
Investor's Business Daily
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
↗
August 30, 2024
"Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money down the road."
Via
Benzinga
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
↗
August 29, 2024
Roivant stock has an outstanding A- Accumulation/Distribution Rating, showing that institutions such as mutual funds are fairly heavy buyers.
Via
Investor's Business Daily
Biohaven Stock Earns Relative Strength Rating Upgrade
↗
August 21, 2024
Biohaven stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 91.
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
↗
August 21, 2024
A Relative Strength Rating upgrade for SpringWorks Therapeutics shows improving technical performance.
Via
Investor's Business Daily
Immunome Stock Sees RS Rating Jump To 91
↗
August 20, 2024
Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.
Via
Investor's Business Daily
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
↗
August 19, 2024
The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
↗
August 19, 2024
Via
Benzinga
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
August 14, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
↗
August 11, 2024
Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them?
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
↗
August 09, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
ADMA stock results show that ADMA Biologics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
